<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01542385</url>
  </required_header>
  <id_info>
    <org_study_id>PRIMACY</org_study_id>
    <nct_id>NCT01542385</nct_id>
  </id_info>
  <brief_title>Primary Reperfusion Secondary Stenting Trial</brief_title>
  <acronym>PRIMACY</acronym>
  <official_title>Immediate vs. Delayed Stenting After Primary Percutaneous Reperfusion in ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research project is to improve how we treat heart attacks. The study will
      assess whether it might not be better to wait a few hours before implanting the coronary
      stent into the coronary artery rather than implanting it immediately, in order to allow the
      drugs to completely dissolve the clot. This might help to reduce the risks of the clot
      migrating and damaging the heart. By delaying coronary stent implantation, we hope to be able
      to reduce the size of the infarction and reduce the risk of suffering from heart failure
      following a heart attack.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PRIMACY trial seeks to assess whether a strategy of delayed stent implantation combined
      with adjunctive anticoagulation is superior to immediate stent implantation at improving
      cardiovascular outcomes in patients with mechanically reperfused ST-elevation Myocardial
      Infarction (STEMI). The investigators hypothesize that delayed stent implantation combined
      with systemic anticoagulation and maximal antiplatelet therapy will reduce the combined
      occurrence of cardiac death, non-fatal myocardial infarction, congestive heart failure, and
      target vessel revascularization at 90 days.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The combined occurence of cardiac death, non-fatal myocardial infarction, congestive heart failure, and urgent target vessel revascularization</measure>
    <time_frame>90 days</time_frame>
    <description>As defined by standardized definitions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>90 days</time_frame>
    <description>As defined by the Bleeding Academic Research Consortium (BARC).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">307</enrollment>
  <condition>ST-elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Immediate stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the stent selection (bare metal vs drug eluting) and implantation will be performed as recommended by current practice guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed stenting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants randomised to delayed stenting will be treated with GPIIb-IIIa inhibitors for 12-18 hours after reperfusion followed by anticoagulation for until the control angiogram, expected no sooner than 18-24 hours after the index reperfusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stent</intervention_name>
    <description>Percutaneous coronary intervention: reperfusion with a thrombectomy catheter or a small balloon angioplasty catheter, followed by coronary stenting</description>
    <arm_group_label>Immediate stenting</arm_group_label>
    <arm_group_label>Delayed stenting</arm_group_label>
    <other_name>Thrombectomy catheter</other_name>
    <other_name>Balloon angioplasty catheter</other_name>
    <other_name>Coronary stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18 and 80 years;

          2. STEMI, presenting within 12 hours of symptoms onset, and persisting for more than 20
             minutes;

          3. ECG that fulfills any of the following criteria: ≥ 2 mm ST elevation in two anterior
             or lateral leads; or ≥ 1 mm ST elevation in two inferior leads; or new left bundle
             branch block (LBBB) with at least 1 mm concordant ST elevation;

          4. Infarct-related artery with TIMI flow 0 or 1 at baseline angiogram;

          5. Successful reperfusion (TIMI 2-3 flow), either spontaneously or after wire passage,
             thrombectomy, small size (≤ 2.0mm) angioplasty catheter, and persisting for more than
             10 minutes;

          6. Infarct related artery with a diameter above 2.5 mm.

        Exclusion Criteria:

          1. Prior STEMI in the qualifying coronary artery;

          2. Coronary dissection following reperfusion;

          3. STEMI caused by acute stent thrombosis or a venous or arterial bypass graft occlusion;

          4. Significant left main disease, as determined by angiography (≥ 50%) or other imaging
             technologies;

          5. Cardiac condition requiring emergent or urgent surgical repair;

          6. Failed thrombolysis and rescue PCI;

          7. High risk of bleeding;

          8. Contraindication to either ticagrelor or GpIIb/IIIa inhibitors;

          9. STEMI with Killip III-IV or cardiogenic shock or presenting as sudden death,
             ventricular fibrillation, or sustained ventricular tachycardia;

         10. Women who are pregnant or breastfeeding;

         11. Creatinine clearance &lt; 20 ml/min;

         12. Other contraindication to PCI;

         13. Participation with another investigational drug or investigational device study within
             30 days prior to randomization (participation to registries is allowed);

         14. Any condition that in the opinion of the investigator would preclude compliance with
             the study protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc E Jolicoeur, MD MSc MHS</last_name>
    <role>Study Chair</role>
    <affiliation>Montreal Heart Institute, Université de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence Joseph, PhD</last_name>
    <role>Study Director</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Caude Tardif, MD</last_name>
    <role>Study Director</role>
    <affiliation>Montreal Heart Institute, Université de Montréal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUM-Hôtel-Dieu de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacré Cœur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional de Lanaudière</name>
      <address>
        <city>St-Charles-Borromée</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR CSSS de Trois Rivières</name>
      <address>
        <city>Trois Rivières</city>
        <state>Quebec</state>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Bastia</name>
      <address>
        <city>Bastia</city>
        <zip>20200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis-Pasteur</name>
      <address>
        <city>Le Coudray</city>
        <zip>28360</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HCL Hopital Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Annecy Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch de Montpellier-Hôpital A. de Villneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Nimes</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Pau</name>
      <address>
        <city>Pau</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse-Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Vichy</name>
      <address>
        <city>Vichy</city>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.onlinecjc.ca/article/S0828-282X(11)00400-4/fulltext</url>
    <description>Canadian Journal of Cardiology Editorial</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Marc Jolicoeur</investigator_full_name>
    <investigator_title>E. Marc Jolicoeur, MD MSc MHS FRCP-C FACC</investigator_title>
  </responsible_party>
  <keyword>Delayed stenting</keyword>
  <keyword>Deferred stenting</keyword>
  <keyword>Late stenting</keyword>
  <keyword>postponed stenting</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>PCI</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>STEMI</keyword>
  <keyword>acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

